- 3470 Laird Rd, Unit 1 Mississauga ON L5L 5Y4
- [email protected]
- (905) 820 – 6000
Reflex Virtual Clinic
In response to COVID-19, our Medical Team has launched Reflex Virtual Clinic. OHIP Covered. Secure by Ontario Telehealth Network.
Existing & new patients can meet with our physicians, Physiotherapists and pharmacists online. Our family doctors and internal medicine specialists will examine you and treat you with minimum contact or exposure. Our pharmacists can also assist you with your medications. You have the option of curbside pick up or home delivery.
Questions or need a doctor’s appointment?
Please complete the Call-Back Request Form and we will call you back as soon as possible, within 24 business hours.
While a cure continues to remain out of reach, the pace of diabetes treatment innovation is faster than ever. Looking back over the past two decades, it’s pretty amazing how far diabetes management has come with new medications and therapies that can make a living with diabetes a whole lot easier as well as longer. This is an exciting time for Diabetes Specialists.
The last ten years brought us more meaningful therapeutic options than anytime before. New classes of medications have proven their worth for tighter diabetes control, Weight loss, Delay of complications. Medications that were mainstream in the 90s and early millennium are now upgraded. For example, one of the most difficult tasks for a diabetic patient is to lose weight. This is part of the side effects of older treatments. Now we have options that allow us to achieve tight diabetes control and enable weight loss.
As we are currently living in a COVID-19 era, it makes sense to talk about my ongoing COVID-19 related research interests.
We know that lung vessel injury is a common finding among hospitalized COVID-19 patients. Patients with severe COVID-19 exhibit a high prevalence of lung vessels damage, which may lead to pulmonary hypertension (high pressure in the lungs) potentially deadly and disabling disease. As the world recovers from the acute stages of the COVID-19 pandemic, it will be faced with new challenges regarding the long-term consequences of lung vessels damage. Given the large number of patients infected by SARS-CoV-2 worldwide, the surge of patients with lung vessels damage could become a major public health problem beyond the acute stages of the pandemic. Therefore, there is an immediate unmet need to gain an in-depth understanding of the clinical relevance of the development of lung vessels abnormalities in the context of the COVID-19 pandemic.
Important Note for New Patients
For easier and faster service, kindly keep your health card handy during the video conference medical appointment.